Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Cash Flows from Operating Activities:
Net loss	$ (4,160,196)	$ (4,452,797)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and Amortization	54,840	33,407
Loss on disposal of property and equipment	12,978	0
Stock Based Compensation	565,039	429,610
Other non-cash expenses	0	34,796
Changes in assets and liabilities:
Prepaid expenses and other receivables	186,281	(456,125)
Accrued interest receivable	(258,523)	(37,396)
Increase in inventory	0	70,759
Accounts payable	138,485	98,118
Liability due to related party	(91,347)	697,182
Other liabilities and accrued expenses	102,898	21,494
Net cash used in operating activities	(3,449,545)	(3,560,952)
Cash Flows from Investing Activities:
Capitalized patent costs	(53,206)	(20,331)
Purchase of property and equipment	(157,825)	(59,666)
Fixed rate savings account	0	4,483,852
Net cash provided by/ (used in) investing activities	(211,031)	4,403,855
Cash Flows from Financing Activities:
Costs incurred in relation to ATM Financing	(40,365)	(161,102)
Costs incurred in relation to public offering	0	(328,302)
Gross proceeds from issuance of common stock in relation to ATM financing	152,492	455,105
Gross proceeds from public offering	0	2,019,743
Gross proceeds from warrant exercise	26,000	64,311
Gross proceeds from unit purchase option	0	100
Repayments of note payable	(40,896)	0
Net cash provided by financing activities	97,231	2,049,855
Net increase/(decrease)/ in cash	(3,563,345)	2,892,758
Effect of exchange rate changes on cash	(71,212)	25,571
Cash at beginning of year	3,740,664	822,335
Cash at end of year	106,107	3,740,664
Supplemental disclosure of non-cash financing activities:
Conversion of Series A preferred stock to common stock	0	137,324
Prepayment of equity compensation	27,400	85,715
Amount of insurance funded through note payable	123,491	0
Forgiveness of payable from a related party	$ 0	$ 302,819